[<sup>68</sup>Ga]Ga-DOTATATE-avid tumor volume, uptake and inflammation-based index correlate with survival in neuroendocrine tumor patients treated with [<sup>177</sup>Lu]Lu-DOTATATE PRRT.
Journal article published in 2022 by
E. Pauwels,
J. Dekervel,
C. Verslype,
Clement Pm,
C. Dooms,
K. Baete,
K. Goffin,
S. Jentjens 
,
K. Van Laere,
E. Van Cutsem,
Deroose Cm
,
K. Van Laere,
E. Van Cutsem,
Deroose Cm
